Radiation Oncology/Therapy: Page 90

Software solutions provide vision of future in Valencia
By Frances Rylands-Monk
New software will soon provide automatic tumor measurements for gold-standard therapy planning at one of Spain's top hospitals. In the longer term, instant evaluation of tumor necrosis in follow-up should be feasible, for timely treatment tailoring once therapy is under way.
October 3, 2011
2011 10 03 11 51 38 741 2011 10 04 Valencia Thumb
Proton therapy firms collaborate
By AuntMinnieEurope.com staff writers
ProTom International has entered into an arrangement with U.K.-based Advanced Proton Solutions (APS) to provide its Radiance 330 proton therapy system for a new APS facility that will be built in London, according to the company.
September 29, 2011
Treatment of rectal cancer varies throughout Europe
By AuntMinnieEurope.com staff writers
What type of treatment a patient diagnosed with rectal cancer receives may be determined by the country where treatment is sought, according to a study conducted by the European Cancer Organisation, whose findings were presented at its annual meeting held last week in Stockholm.
September 28, 2011
RaySearch creates sales network in Italy
By AuntMinnieEurope.com staff writers
Swedish radiation therapy firm RaySearch Laboratories has entered into an exclusive distribution agreement with Technologie Avanzate of Torino, Italy, to represent the company in Italy.
September 28, 2011
Elekta claims procedure growth in Scandinavia
By AuntMinnieEurope.com staff writers
Radiation oncology firm Elekta has stated that image-guided radiation therapy treatments have increased by 20% in the past eight months at Finland's Helsinki University Central Hospital, the time when an Axesse stereotactic system was installed.
September 28, 2011
Varian/Brainlab grows in Scotland
By AuntMinnieEurope.com staff writers
Radiation therapy vendors Varian Medical Systems and Brainlab announced that they have installed a Novalis Tx radiotherapy system at the Edinburgh Cancer Centre of the Western General Hospital in Scotland.
September 27, 2011
Radiopharmaceutical targets bone metastases in prostate cancer
By Cynthia E. Keen
An experimental drug that delivers small doses of radiation to bone metastases in prostate cancer patients has shown that it can prolong survival significantly, according to research presented at the European Multidisciplinary Cancer Congress, held in Stockholm this week.
September 27, 2011
Breast cancer study shows benefits of double therapy
By Reuters Health
STOCKHOLM (Reuters) - Giving breast cancer patients radiotherapy and chemotherapy at the same time significantly cuts the risk of recurrence and should be considered as a new treatment approach across the world, cancer experts said on Sunday.
September 25, 2011
Reuterslogo
Cancer cost 'becoming unsustainable' in rich nations
By Reuters Health
STOCKHOLM (Reuters) - An explosion of new technologies and treatments for cancer coupled with a rapid rise in cases of the disease worldwide mean cancer care is rapidly becoming unaffordable in many developed countries, oncology experts said on Monday.
September 25, 2011
Reuterslogo
Tips for averting misdiagnoses in PET/CT
By Cynthia E. Keen
The fusion of metabolic and morphological data should improve diagnostic accuracy, but mistakes can still occur. Some malignancies that have a low affinity to FDG may be missed if the corresponding CT scan is not scrutinized carefully.
September 25, 2011
2011 09 23 13 51 23 341 2011 09 26 Pet Ct Thumb
Elekta completes Nucletron purchase
By AuntMinnieEurope.com staff writers
Oncology firm Elekta announced it has completed its acquisition of radiation therapy firm Nucletron for 365 million euros ($522.1 million U.S.) in cash.
September 14, 2011
Elekta gets OK for Nucletron buy
By AuntMinnieEurope.com staff writers
Oncology firm Elekta has obtained regulatory approval for its proposed acquisition of radiation therapy firm Nucletron for 365 million euros ($522.1 million U.S.) in cash.
September 12, 2011
Previous Page
Page 90 of 127
Next Page